Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
WuXi STA, a global Contract Research, Development, and Manufacturing Organization (CRDMO) has added two 2,000 L reactors and a large-scale continuous purification system for peptide manufacturing at its Changzhou campus.
read more
Thursday, February 23, 2023
AllCells®, a Discovery Life Sciences™ company announced the expansion of its apheresis network with the addition of two new centers in Houston, Texas, and Huntsville, Alabama. These new centers complement AllCells' existing presence in two major U.S....
read more
Thursday, January 12, 2023
CordenPharma is pleased to announce the signing of a multi-year agreement commencing in 2023 for the contract manufacturing of a large-volume peptide at its CordenPharma Colorado facility.
read more
Tuesday, January 10, 2023
Sterling Pharma Solutions announced the completion of its acquisition of an active pharmaceutical ingredient (API) manufacturing facility in Ringaskiddy, Ireland, from Novartis, in a deal that was initially announced in March 2022.
read more
Agilent Technologies Inc. announced it is investing approximately $725 million to double manufacturing capacity of therapeutic nucleic acids in response to rapid growth of the $1 billion market and strong demand for the company’s high-quality active ...
read more
Monday, December 05, 2022
Lonza announced the start of new mid-scale manufacturing assets at its API manufacturing center in Nansha, China.
read more
Monday, November 21, 2022
Cambrex entered an agreement to acquire Snapdragon Chemistry, a leading US-based provider of chemical process development services to a broad range of emerging and established biopharma customers.
read more
Thursday, November 17, 2022
GE Healthcare’s Pharmaceutical Diagnostics business announced an $80 million investment to increase manufacturing capacity by 30 percent at its Active Pharmaceutical Ingredients (API) site in Lindesnes, Norway.
read more
Tuesday, November 08, 2022
Insilico Medicine, a clinical stage artificial intelligence driven drug discovery company, announced a multi-year, multi-target strategic research collaboration with Sanofi. Under the terms of the agreement, the collaboration will leverage Insilico ...
read more
Thursday, October 20, 2022
Farmabios, Novasep and PharmaZell officially announced that they are coming together under the new brand Axplora.
read more
Thursday, October 20, 2022
Mikart entered into a collaboration agreement with Fluid Pharma Ltd, a technology licensing company, to advance the application of Fluid Pharma's proprietary MicroCoat™ technology in new therapies for pediatric, geriatric, and oral liquid modified ...
read more
Wednesday, October 19, 2022
C2 PHARMA, a pharmaceutical group focused on manufacturing and supplying ophthalmic and niche active pharmaceutical ingredients (APIs) globally, is expanding the API product portfolio. Tropicamide API is launching with regulatory filings in both ...
read more
Tuesday, October 11, 2022
Mikart, LLC to collaborate with Nano PharmaSolutions, who has a proprietary NanoTransformer™ that enhances the solubility of pharmaceutical active ingredients (API).
read more
Tuesday, October 11, 2022
The Outsourcing Facilities Association (OFA) announced that it has reached a settlement agreement with the FDA that spurs the FDA to promptly review long-pending nominations for active pharmaceutical ingredients for use by FDA-registered outsourcing ...
read more
Thursday, October 06, 2022
Barentz International, a global life science ingredients distributor, has acquired Viachem, Ltd., a specialty distributor of life science ingredients and specialty chemicals.
read more